Compare Cigna Corp (CI) vs J M Smucker Co (SJM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cigna Corp vs J M Smucker Co — how do they compare? Cigna Corp trades at $272.72 (market cap $73.56B), while J M Smucker Co trades at $117.46 (market cap $12.84B). The key difference: Cigna Corp is far larger — about 5.7× J M Smucker Co's market cap, and J M Smucker Co pays the higher dividend (3.73%). Which is the better fit depends on your goals.
| CI | SJM | |
|---|---|---|
Market Cap | $73.56B | $12.84B |
Sector | Health | Consumer Staples |
52-Week High | $311.00 | $126.35 |
52-Week Low | $244.41 | $89.53 |
Enterprise Value | $98.27B | $19.87B |
Dividend Yield | 2.24% | 3.73% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cigna (CI) trades at $282.49, up 2.63% with strong earnings beats in recent quarters. The stock shows bearish technical signals but benefits from low valuation ratios like a P/E of 11.68 and P/S of 0.27. Recent Q2 2026 results exceeded expectations, with EPS of $7.78 beating estimates, and the company raised its full-year guidance to at least $30.45 adjusted EPS, reflecting robust growth in health services and insurance segments.
The outlook is positive due to consistent earnings outperformance and raised guidance, though technical weakness and competitive pressures pose risks. Analyst consensus is strongly bullish with a $338.90 price target, indicating ~20% upside potential from current levels, supported by dividend payments and institutional accumulation.
SJM trades at $120.16, up 1.14% today, with a bullish technical signal and strong analyst support. Recent earnings beat expectations in Q4 2025 and Q1 2026, though Q2 2026 results are pending. The company maintains a solid dividend track record, raising payouts for 25 consecutive years. Revenue growth is stable, but negative net income and ROE highlight profitability challenges amid high debt levels.
Outlook is cautiously optimistic with a consensus price target of $125.11 offering 4% upside. Key risks include persistent negative margins and elevated leverage, while opportunities lie in cost controls and brand strength. Investors should weigh dividend reliability against earnings volatility in the consumer staples sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cigna Corp
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →About J M Smucker Co
J.M. Smucker is a packaged food company that primarily operates in the U.S. retail channel (87% of fiscal 2022 revenue), but also in U.S. food-service (7%), and international (6%). Its largest segment is pet food and treats (36% of 2022 revenue), with popular brands such as Milk-Bone, Meow Mix, 9Lives, Kibbles 'n Bits, Nature's Recipe, and Rachael Ray Nutrish. Its second-largest category is coffee (35% across channels) with the number-two brand Folgers and number-six Dunkin'. Other large categories are peanut butter (10%), with number-one Jif, fruit spreads (5%) with number-one Smucker's, and frozen hand-held foods (6%) with number-one Uncrustables.
Read more on SJM →
